All News

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

A new review finds immediate release nifedipine offers comparable safety and efficacy to IV labetalol and hydralazine in managing severe hypertension during pregnancy.

A new study reveals Black women have larger, more U-shaped levator hiatus dimensions than White women, highlighting potential implications for pelvic floor disorder.

SARS-CoV-2 infection during pregnancy alters placental gene expression and increases pathology, especially when contracted in the first trimester.

Driven by economic concerns and shifting family planning trends, the US fertility rate dropped below 1.6 births per woman, despite a slight rise in total births.

A new meta-analysis found no significant difference in wound complications between metal staples and subcuticular sutures for post-cesarean skin closure in obese patients.

A new study finds that patient-reported screening methods are highly effective for determining medication abortion eligibility.

A new ACOG clinical guidance offers updated recommendations on umbilical cord management for preterm births based on recent evidence and analysis.

Stephanie Pearson, MD, provides some tips for ergonomics within obstetrics and gynecology.

The World Health Organization’s evidence-based recommendations aim to improve care and outcomes for pregnant women with sickle cell disease.

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study finds that intrahepatic cholestasis of pregnancy diagnosis before 32-weeks’ gestation increases the risk of adverse outcomes.

Kephera Diagnostics announced the launch of EndomTest, a noninvasive blood test for endometriosis, promising faster diagnoses and improved patient care.

A study finds that a uniform labor induction protocol did not reduce racial disparities in cesarean deliveries or maternal health outcomes.

The FDA has granted priority review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.

A new study reveals that stem cell treatment activates oocytes in 70% of women with ovarian failure.

A new study finds that restrictive abortion legislation significantly increases maternal health risks in pregnancies with life-limiting fetal diagnoses.

Study finds USPSTF guidelines label 89% of pregnancies as at risk for preeclampsia, but moderate risk factors offer limited value in guiding aspirin use.

Learn the truth about estrogen therapy, including its safety, benefits, and the critical differences between local and systemic hormone treatments.

Women with hypertensive disorders of pregnancy are more likely to never start or stop breastfeeding early, according to a recent study.

A new study highlights the urgent need for standardized, globally applicable guidelines to improve the diagnosis and management of placenta accreta spectrum.

Experts debate the risks and benefits of SSRIs during pregnancy, emphasizing the need for better education and transparency in treatment options.

A new review reveals that maternal depression significantly impairs bonding, sensitivity, and emotional engagement among mothers.

New research suggests oxytocin could help reduce mood disturbances caused by sleep disruption during menopause and postpartum.

Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.

Nearly one-third of women with premature ovarian insufficiency experience depressive symptoms, according to a recent study.

Infants born preterm or with complications face higher risks of chronic conditions in adulthood, highlighting policy and health care needs.